We kindly invite you to the lecture of dr Joanna Achiger-Kawecka titled “Understanding 3D genome disorganisation in cancer to identify new therapeutic targets” at 9:15 on Thursday 23rd May at CZT UAM. The talk will be followed by career-advisory meeting for PhD students and postdocs at 10:30. More information about the speaker below.

The seminar and following meeting will exceptionally take place at the Centre of Advanced Technologies in the room D111/4-5 (last building at the Morasko Campus on the right side , go through the main entrance, room at the first floor).

Let us know in case you would like to meet with the speaker, there will be 2-3 30 min time slots available => contact Michał Gdula (michal.gdula@amu.edu.pl).

Twitter add: https://x.com/UAM_IBMiB/status/1789975983858106700

Dr Joanna Achinger-Kawecka

Group Leader, The Garvan Institute of Medical Research, Sydney, Australia and Senior Lecturer, UNSW Sydney, Australia

Title: Understanding 3D genome disorganisation in cancer to identify new therapeutic targets

Dr Joanna Achinger-Kawecka is a Group Leader of the 3D Epigenome in Cancer group at the Garvan Institute of Medical Research and Conjoint Senior Lecturer at St Vincent’s Clinical School, UNSW Sydney. Joanna completed her PhD in 2014 at the University of Tuebingen, Germany supported by the prestigious Marie Sklodowska-Curie Fellowship, studying epigenetic biomarkers in breast cancer. Following her PhD, Joanna joined the Epigenetics Research laboratory of Prof Susan Clark at the Garvan Institute, where she established cutting-edge experimental and computational approaches to study the 3D genome organization. In 2023, Joanna became an independent group leader at the Garvan Institute. Her research group focuses on studying the role of the 3D genome architecture in gene deregulation in treatment-resistant cancers. In her talk, Joanna will discuss how the 3D genome and epigenome are altered in breast and prostate cancer and how these 3D epigenome changes can be potentially targeted with epigenetic therapies.